Depression as prognostic indicator of survival, nutritional status in head and neck cancer
the ONA take:
Presence of depression can have a significant impact on patient quality of life and treatment outcomes. This study evaluated the association between presence of pretreatment depression and pretreatment quality of life (QOL), nutritional status, and survival outcomes in patients with head and neck squamous cell carcinoma (HNSCC).
The researchers enrolled 241 patients with previously untreated HNSCC who underwent curative treatments. The Beck Depression Inventory (BDI)-II was used to determine depressive (score ≥14) vs. nondepressive (score <14) patients.
Participants also completed the European Organization for Research and Treatment of Cancer (EORTC) 30-item Core QOL Questionnaire (QLQ-C30) and the EORTC QLQ Head and Neck module (QLQ-H&N35).
Univariate and multivariate analyses were used to assess whether presence of depression was associated with overall survival, disease-free survival (DFS), or posttreatment changes in nutritional status and laboratory data.
Pretreatment depression was present in 60 patients. Study findings showed 3-year overall survival rates, 3-year DFS rates, and pretreatment serum albumin levels were lower in the depressive patients.
EORTC QLQ-C30 and QLQ-H&N35 scores differed between depressive and nondepressive patients on all items except feeding tube, nutritional supplement, and problem with mouth opening.
The researchers conclude that pretreatment depression has a significant impact on pretreatment QOL, nutritional status, and survival outcomes in patients with HNSCC.
Presence of depression can have a significant impact on patient quality of life and treatment outcomes.
- Immunotherapy May Benefit Some Patients with Papillary Thyroid Carcinoma
- New Study Questions Standard Dosage for Treating Metastatic Non-Small Cell Lung Cancer
- Superior Tolerability, Efficacy With Alectinib in Treatment-Naïve ALK-poistive NSCLC
- Adding Pertuzumab to Adjuvant Therapy Is Beneficial for Some Women with Early Breast Cancer
- Clinical Trials May Benefit Oncology Patients
- Survivorship Care Plans: Providing A Blueprint for Health Care After Cancer
- Cancer Recurrence Fear Reduced by Novel Psychological Intervention
- Multifaceted Role of the Nurse Navigator Includes Palliative, Supportive Care
- Patient Navigators Found to Boost Lung Cancer Screening Rates
- Breast Cancer Diagnosis and Nurse Navigation Survey
- Radiotherapy is Essential in Treating Brain Tumors But Associated With Significant Adverse Events
- Prostate-specific PET and CT Imaging Improves Detection of Disease and Patient Care
- Lenvatinib Improves OS, PFS in Radioiodine-Refractory Differentiated Thyroid Cancer in All Older Patients
- Breast Cancer Overdiagnosis Also a Result of Screening Mammography Programs
- Use of Aspirin, NSAIDs Correlates with Improved Overall Survival in Colorectal Cancer
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|